# Umecrine Cognition AB: Research, Gothenburg, Sweden

> Umecrine Cognition AB: Umecrine Cognition AB is a clinical-stage biopharmaceutical company based in Stockholm, Sweden, and a subsidiary of Umecrine AB.

Source: https://millionrounds.com/startup/umecrine-cognition-ab (Millionrounds; every figure on the page links to its filing or article)

Sweden · [Research startup](https://millionrounds.com/companies)

# Umecrine Cognition AB

Umecrine Cognition AB is a clinical-stage biopharmaceutical company based in Stockholm, Sweden, and a subsidiary of Umecrine AB.

Funding reported Last round: Convertible note

Research Gothenburg, Sweden

Company summary

- **Founded:** 2000 26 years old
- **Team:** 10 1 to 10 people
- **Funding reported:** 50.4M as listed, currency not stated
- **Last round:** Convertible note Nov 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Umecrine Cognition AB has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Umecrine Cognition AB

Umecrine Cognition AB is a clinical-stage biopharmaceutical company based in Stockholm, Sweden, and a subsidiary of Umecrine AB.

The company focuses on developing innovative small-molecule therapeutics for neurological disorders linked to neuroinflammation and GABA-A receptor overactivation in the central nervous system. Umecrine Cognition specializes in first-in-class drug candidates aimed at addressing cognitive impairment, central fatigue, and alertness deficits associated with conditions like chronic liver disease. Its lead candidate, golexanolone, is designed to normalize brain signaling and alleviate symptoms in conditions such as Primary Biliary Cholangitis (PBC) and Hepatic Encephalopathy (HE). The company is actively conducting clinical studies and has received FDA Orphan Drug Designation for golexanolone in PBC. Umecrine Cognition is committed to advancing its pipeline and exploring partnerships for commercialization, targeting significant patient populations with unmet medical needs.

## What company datasets say Umecrine Cognition AB raised

Funding, as reported

Reported in all **50.4M** in the source's currency

Rounds **3**

Last round **Convertible note**

Last round date **Nov 2023**

Investors listed **6**

## The company, in detail

What they build

Known for

biotechnology research hepatic encephalopathy cognitive disorders gabaa receptor neurological disorders primary biliary cholangitis drug development cognitive function biotech fatigue parkinsons disease b2b pbc golexanolone

Built with from their website

Google Maps Google Tag Manager WordPress Multisite WordPress.org PWA CloudFlare Viewport Meta Priority Hints Microsoft Exchange FlexSlider

+8 more

Microsoft Azure Hosting MySQL PrimeNG Microsoft 365 Apps & Services Mobile Friendly CampaignMonitor Loopia Open Graph

- **Sector:** Research
- **Industry code:** NAICS 541714, SIC 8731
- **Region:** Vaestra Goetaland County
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/umecrine-cognition)

## Research in Sweden

Startups like it

- [**Anocca** Södertälje · founded 2014](https://millionrounds.com/startup/anocca)
- [**SmartCella Holding AB** Botkyrka · founded 2014](https://millionrounds.com/startup/smartcella-holding-ab)
- [**Navinci** Uppsala · founded 2004](https://millionrounds.com/startup/navinci)
- [**AnaCardio** Gothenburg · founded 2017](https://millionrounds.com/startup/anacardio)
- [**Akiram Therapeutics** Uppsala · founded 2021](https://millionrounds.com/startup/akiram-therapeutics)
- [**Strike Pharma AB** Uppsala · founded 2020](https://millionrounds.com/startup/strike-pharma-ab)
- [**Ljusgårda AB** Tibro · founded 2017](https://millionrounds.com/startup/ljusg-rda-ab)
- [**Empros Pharma** Gothenburg · founded 2014](https://millionrounds.com/startup/empros-pharma)

## Is this your company?

Add your raise, your deck and your story, and put Umecrine Cognition AB in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)